Valuation: DarioHealth Corp.

Market Cap 26.7M 23.8M 21.77M 19.82M 37.36M 2.52B 38.37M 261M 105M 1.34B 100M 98.08M 4.22B P/E 2026 *
-0.68x
P/E 2027 * -1.21x
Enterprise Value 38.05M 33.91M 31.01M 28.24M 53.24M 3.6B 54.67M 373M 149M 1.9B 143M 140M 6.01B EV / Sales 2026 *
1.75x
EV / Sales 2027 * 1.76x
Free-Float
78.35%
Yield 2026 *
-
Yield 2027 * -
1 day-8.25%
1 week-17.68%
Current month-9.17%
1 month-53.02%
3 months-64.43%
6 months-65.89%
Current year-76.05%
1 week 2.69
Extreme 2.69
3.14
1 month 2.69
Extreme 2.69
6.36
Current year 2.69
Extreme 2.69
13.64
1 year 2.69
Extreme 2.69
14.77
3 years 2.69
Extreme 2.69
52
5 years 2.69
Extreme 2.69
385.5
10 years 2.69
Extreme 2.69
1,880
Manager TitleAgeSince
Corporate Officer/Principal - 11/08/2011
Chief Executive Officer 52 09/08/2013
Director of Finance/CFO 38 01/01/2021
Director TitleAgeSince
Chairman 52 23/11/2014
Director/Board Member 68 12/11/2013
Director/Board Member 57 23/11/2014
Date Insider Type Main position Quantity % Market Cap. Importance
9/24/26 A Free

Chairman

54,000 0.5510%
9/24/26 A Free

Director

61,000 0.6225%
9/24/26 A Free

Director

28,000 0.2857%
Change 5-day change 1-year change 3-year change Capi.($)
-8.25%-17.68%-79.95%-89.79% 26.7M
-1.65%+8.64%-8.78%+18.53% 197B
-1.35%+7.48%-6.32%+21.31% 128B
-0.11%+7.96%+15.97%+44.49% 128B
+1.51%+7.72%-39.31%+10.16% 99B
-4.05%+2.77%-4.05%+74.04% 64.82B
+2.08%+7.67%+21.07%-17.52% 58.17B
-3.99%+16.45%-6.87%+56.23% 52.84B
-6.98%-14.56%-12.60%+42.69% 50.69B
-0.79%+6.84%+4.91%-6.33% 37.23B
Average -2.36%+4.57%-11.59%+15.38% 81.54B
Weighted average by Cap. -1.35%+7.56%-5.19%+26.68%

Financials

2026 *2027 *
Net sales 21.75M 19.38M 17.73M 16.14M 30.43M 2.06B 31.25M 213M 85.15M 1.09B 81.63M 79.88M 3.43B 29.49M 26.28M 24.03M 21.89M 41.26M 2.79B 42.37M 289M 115M 1.48B 111M 108M 4.66B
Net income -32.48M -28.95M -26.48M -24.11M -45.45M -3.07B -46.68M -318M -127M -1.63B -122M -119M -5.13B -22.08M -19.68M -18M -16.39M -30.9M -2.09B -31.73M -216M -86.46M -1.11B -82.88M -81.1M -3.49B
Net Debt 11.35M 10.11M 9.25M 8.42M 15.88M 1.07B 16.3M 111M 44.43M 568M 42.59M 41.68M 1.79B 25.07M 22.34M 20.44M 18.61M 35.08M 2.37B 36.03M 246M 98.17M 1.25B 94.11M 92.09M 3.96B
Projected Income Statement - Annual - DarioHealth Corp.
Logo DarioHealth Corp.
DarioHealth Corp. is a global digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by data analytics, software, and personalized coaching. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
Employees
163
Date Price Change Volume
05/11/26 $2.725 -8.25% 70,670
04/11/26 $2.970 -1.00% 58,715
03/11/26 $3.000 -0.99% 71,591
02/11/26 $3.030 +1.00% 76,093
30/10/26 $3.000 -9.37% 55,533
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - DarioHealth Corp.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
2.725USD
Average target price
12.33USD
Spread / Average Target
+352.60%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - DarioHealth Corp.
  1. Stock Market
  2. Stocks
  3. DRIO Stock